<DOC>
	<DOCNO>NCT00962260</DOCNO>
	<brief_summary>This open-label expand access trial prGCD patient Gaucher disease require enzyme replacement therapy ( ERT ) treat imiglucerase dose reduce discontinue due shortage product .</brief_summary>
	<brief_title>Expanded Access Trial Plant Expressed Recombinant Glucocerebrosidase ( prGCD ) Patients With Gaucher Disease</brief_title>
	<detailed_description>Gaucher disease , prevalent lysosomal storage disorder , cause mutation human glucocerebrosidase gene ( GCD ) , map chromosome 1 q21-q31 , lead reduce activity lysosomal enzyme glucocerebrosidase thereby accumulation substrate glucocerebroside ( GlcCer ) cell monocyte-macrophage system . This accumulation lead visceral manifestation hepatosplenomegaly , anemia thrombocytopenia , well skeletal feature less frequently also lung involvement . prGCD plant cell express recombinant glucocerebrosidase enzyme treatment Gaucher disease . Expression proteins plant cell culture highly efficient , require post-expression modification protein , susceptible contamination agent viruses pathological human . prGCD safety observe treatment protocol patient non-neuronopathic Gaucher disease require enzyme replacement therapy . Eligible patient receive intravenous ( IV ) infusion prGCD every two week . The dose prGCD equal patient 's previous imiglucerase dose reduction discontinuation due shortage . The infusion administer select medical center .</detailed_description>
	<mesh_term>Gaucher Disease</mesh_term>
	<criteria>Males female , 18 year old Diagnosis Gaucher disease treat historically imiglucerase Able provide write informed consent Currently take another experimental drug condition History allergy carrot Previous infusion reaction suspect allergic nature Cerezyme® Ceredase® receive premedication prevent infusion reaction Allergy betalactam antibiotic Presence medical , emotional , behavioral psychological condition judgment Investigator would interfere patient 's compliance requirement study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>glucocerebrosidase</keyword>
	<keyword>enzyme replacement therapy</keyword>
	<keyword>Gaucher disease</keyword>
	<keyword>plant cell culture</keyword>
	<keyword>splenomegaly</keyword>
	<keyword>hepatomegaly</keyword>
	<keyword>anemia</keyword>
	<keyword>thrombocytopenia</keyword>
</DOC>